Columbus / Amsterdam / Lyon / Rockville / Chennai / Los Angeles / Lisbon / Catalonia / Brussels / /
Company
Nyitray AG / Moscicki AB / /
Continent
Europe / Australia / North America / /
Country
Netherlands / France / Japan / Australia / India / Costa Rica / Belgium / United States / Spain / /
Currency
pence / / /
Facility
The Ohio State University Comprehensive Cancer Center / Samuel Oschin Comprehensive Cancer Institute / Catalan Institute of Oncology / University of Antwerp / Scientific Institute of Public Health / National Cancer Institute / VU University Medical Center / Cedars Sinai Medical Center / /
IndustryTerm
prevention of oropharyngeal cancer / prevention of cervical cancer / established clinical infrastructure / treatment of HPV-related disease / Treatment of early stage cancers / Prevention of Oropharyngeal and Cervical Cancers / care for recurrent or metastatic disease / therapy for early-stage cervical cancer / pre-existing clinical infrastructure / prevention of HPVassociated noncervical cancers / anatomic site / care for oropharyngeal cancers / /
MedicalCondition
oropharyngeal cancer / Periodontitis / oral human papillomavirus infection / HIV / bacterial vaginosis / oropharyngeal cancers / HPV infection / head and neck cancer ( mach - nc ) / oral HPV16 infection / chronic inflammation / squamous-cell carcinoma / cervical human papillomavirus infection / squamous cell carcinomas / head cancers / Etiology Oncogenic HPV infection / HPV-related cancer / cervical HPV infection / tumor / leukoplakia / HPV16 infection / oral HPV infection / Cancer / predominantly oropharyngeal cancers / tumors / early cervical cancer / HPV-related disease / HPV / carcinogenesis / cervical cancer / oral and oropharyngeal carcinomas / chronic / J. Cancer / genital infection / Both oral and cervical HPV infections / cervical intraepithelial neoplasia / cervical HPV infections / high-risk early-stage cancer / human papilloma virus / human papillomavirus-associated cancers / human papillomavirus-positive cancer / cervical infections / AIDS / neck cancers / HPV-caused cancer / Infection / cervical carcinomas / metastases / infectious female cases / oral HPV infections / et al. infections / cervical cancers / Oral cancer / nasopharyngeal cancer / oropharyngeal cancers Epidemiologic trait Cervical cancer / prevalent oral human papillomavirus infection / Herpes / infectious / Carcinoma / J Cancer / tonsillar cancer / early-stage cervical cancer / high-risk squamous-cell carcinoma / translational active human papillomavirus infection / genital human papillomavirus infection / oropharyngeal and oral cavity cancers / Demographic differences Oral HPV infection / head and neck cancer / cancer of the oropharynx / MS / infections / Periodontal disease / genital HPV infection / cancers / orodigestive cancer / HeLa cervical carcinoma / pharyngeal cancers / oropharyngeal and cervical cancers / squamous cell carcinoma / disease / Cancer IAfRo / Cancer of the cervix / cervical carcinoma / tooth loss / invasive cervical cancers / persistent viral infection / squamous cell cancers / HPV infection A / associated cancers / anogenital cancers / tonsillar carcinoma / carcinomas / cell carcinomas / Chronic periodontitis / oropharynx cancers / oral cavity cancer / herpes simplex / invasive cervical cancer / /
World Health Organization / Scientific Institute of Public Health / Cedars Sinai Medical Center / Institut National / European Commission / OH Institut Catal / The Ohio State University / National Cancer Institute / VU University Medical Center / University of Antwerp / Department of Pathology / Unit of Cancer Epidemiology / Division of Cancer Epidemiology and Genetics / Belgian Foundation Against Cancer / Samuel Oschin Comprehensive Cancer Institute / U.S. Food and Drug Administration / Ohio State University Comprehensive Cancer Center / International Agency for Research / /
Person
Jean Louis Lafebvre / Lisa Licitra / Silvia Franceschi / Hisham Mehanna / Maura L. Gillison / Jan Klozar / Gardner W. Cancer / Xavier Castellsague / Jean Lacau St. Guily / /
Position
HPV-related head / oropharyngeal and non-oropharyngeal head / representative / 16-positive and human papillomavirus 16negative head / lymph node-positive head / locally advanced head / Cao / Harari PM / HPVnegative head / /
Product
cisplatin / Nokia MD-4 Speakers / paclitaxel / /
Region
Northern Europe / Western Europe / Southern Europe / Eastern Europe / /